AB Magnitude Ventures Group
VC Fund
AB Magnitude Ventures Group is an investment firm.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries AB Magnitude Ventures Group invests in
Stages AB Magnitude Ventures Group invests in
Countries AB Magnitude Ventures Group invests in
Investment Focus
Industry
- Health Care 3 (60%)
- Biotechnology 3 (60%)
- Medical 2 (40%)
- Therapeutics 2 (40%)
Stage
- Series A 2 (40%)
- Seed 1 (20%)
- Series C 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ArrePath
|
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections. | Seed / Jun 23, 2025 | |
Myrobalan Therapeutics
|
Myro Therapeutics is a biotechnology company that focuses on the development of therapeutic solutions for Central Nervous System (CNS) disorders. The company's approach is rooted in a deep understanding of disease biology and mechanisms, which allows for the selection of targets that can effectively combat these disorders. Myro Therapeuticshas a dedicated team of scientists who work tirelessly to advance the company's research and development efforts. The company has recently celebrated its second anniversary and has also moved into a new office space, indicating a period of growth and expansion. | $24M / Series A / Jan 10, 2024 | |
Odyssey Therapeutics
|
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines. | $101M / Series C / Dec 05, 2023 | |
Oloren AI
|
Oloren AI offers a molecular descriptor that leverages information from millions of publically curated datasets. The company was founded in 2021 and is headquartered in San Diego, California, United States. | $300K / Pre-Seed / Aug 31, 2022 | |
BAKX Therapeutics
|
BAKX Therapeutics is a provider of cancer treatment. | $25M / Series A / Nov 18, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does AB Magnitude Ventures Group invest in?
AB Magnitude Ventures Group invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did AB Magnitude Ventures Group last invest?
The most recent investment recorded for AB Magnitude Ventures Group closed in Jun 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
